Apollomics, Inc. (NASDAQ:APLMW) Short Interest Up 16.7% in March

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 52,500 shares, an increase of 16.7% from the March 15th total of 45,000 shares. Based on an average daily volume of 17,900 shares, the days-to-cover ratio is currently 2.9 days.

Apollomics Price Performance

APLMW traded up $0.01 during trading hours on Tuesday, reaching $0.03. 720 shares of the company’s stock traded hands, compared to its average volume of 21,131. The firm has a 50-day moving average price of $0.03 and a 200 day moving average price of $0.03. Apollomics has a 52-week low of $0.01 and a 52-week high of $0.13.

Hedge Funds Weigh In On Apollomics

Large investors have recently bought and sold shares of the business. Ionic Capital Management LLC purchased a new position in Apollomics during the 1st quarter valued at $30,000. Shaolin Capital Management LLC purchased a new position in Apollomics during the 1st quarter valued at $33,000. Finally, ATW Spac Management LLC purchased a new position in Apollomics during the 1st quarter valued at $39,000.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.